A ‘brain-first’ mouse model of progressive alpha-synuclein pathology via intranasal rotenone administration
Year: 2026
Type: article
Abstract: The precise etiology of Parkinson’s disease (PD) is still poorly understood, but it is thought to arise due to an intricate relationship between genes and the environment. Our study takes a unique approach to understanding the effect of environmental factors on the onset and progression of α-synuclein (aSyn) pathology, a key feature of PD, from the olfactory bulb (OB) to other brain regions. In the present study, we evaluated the time-dependent progression of PD-like pathology by administering rotenone intranasally for 5.5 months in C57BL/6 male mice. We performed olfactory and motor tests and examined aSyn accumulation, glial cell activation, and dopaminergic (DAergic) neurodegeneration after 3, 4, and 5.5 months of rotenone exposure by immunoblotting and immunofluorescence techniques. We observed a time-dependent progression of aSyn accumulation from the OB to other brain regions, including the mid-brain and cortex. Consistently, we observed a time-dependent behavioral impairment, OB atrophy, progression of aSyn pathology, neuroinflammation, and neurodegeneration. Our findings also established a link between distinct astrocyte activation and DAergic activity. In conclusion, this chronic and progressive mouse model mimics the brain-first type of progression of PD-like pathology in some PD patients, opening the possibility for testing potential disease-modifying interventions.
Source: npj Parkinson s Disease
Institutions: National Institute of Pharmaceutical Education and Research - Ahmedabad, The University of Texas at Austin, Parul University, Masaryk University, German Center for Neurodegenerative Diseases, Universitätsmedizin Göttingen, Algarve Biomedical Center, University of Algarve, Newcastle University, Central European Institute of Technology – Masaryk University, St. Anne's University Hospital Brno, International Clinical Research Center, St. Anne's University Hospital Brno
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,890
Funders: National Institute of Pharmaceutical Education and Research, Ahmedabad, European Commission, Department of Biotechnology, Ministry of Science and Technology, India, Ministerstvo Školství, Mládeže a Tělovýchovy, National Institute of Pharmaceutical Education and Research, Raebareli, NextGenerationEU
OpenAlex ID: W7221007124
